Loading…

The clinical usefulness of natural killer cell activity in patients with suspected or diagnosed prostate cancer: an observational cross-sectional study

To investigate the clinical usefulness of natural killer cell activity (NKA) for detection of prostate cancer (PCa) and prediction of Gleason grade. We prospectively enrolled 221 patients who underwent transrectal ultrasound-guided prostate biopsy for suspected PCa due to elevated prostate-specific...

Full description

Saved in:
Bibliographic Details
Published in:OncoTargets and therapy 2018-01, Vol.11, p.3883-3889
Main Authors: Song, Wan, Yu, Ji Woong, Jeong, Byong Chang, Seo, Seong Il, Jeon, Seong Soo, Lee, Hyun Moo, Choi, Han Yong, Kang, Eun-Suk, Jeon, Hwang Gyun
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c507t-3a303685b4e8ccb62d5c4e1ee2d2f7cf67f54c313e05c22feaf035a3a6f7c5023
cites
container_end_page 3889
container_issue
container_start_page 3883
container_title OncoTargets and therapy
container_volume 11
creator Song, Wan
Yu, Ji Woong
Jeong, Byong Chang
Seo, Seong Il
Jeon, Seong Soo
Lee, Hyun Moo
Choi, Han Yong
Kang, Eun-Suk
Jeon, Hwang Gyun
description To investigate the clinical usefulness of natural killer cell activity (NKA) for detection of prostate cancer (PCa) and prediction of Gleason grade. We prospectively enrolled 221 patients who underwent transrectal ultrasound-guided prostate biopsy for suspected PCa due to elevated prostate-specific antigen (PSA) >2.5 ng/mL or abnormal findings on digital rectal examination (n=146), or who were diagnosed with PCa (n=75) between 2016 and 2017. The NKA was compared according to PCa and Gleason grade. Correlation analysis was used to evaluate associations among NKA, PCa, and Gleason grade, and expressed using distribution dot plots. The absolute risk and relative risk of PCa, and odds ratios at different cut-off values of NKA were calculated. Of the total 221 patients, PCa was identified in 135 (61.9%) patients. When patients were divided according to PCa, there was no significant difference in NKA (1,267.6 vs 1,198.9 pg/mL, =0.491). Furthermore, in 135 patients with PCa, the NKA was not significantly different according to Gleason grade ( =0.893). These results were not changed when confined to the patients with PSA between 2.5 and 10.0 ng/mL ( =0.654 and =0.672, respectively). In addition, there was no significant difference in the risk of PCa at different cut-off values of NKA. These results indicate that NKA does not appear to be very useful for detection of PCa and prediction of Gleason grade. Further large multi-institutional studies are required to verify the role of NKA in PCa detection and Gleason grade prediction.
doi_str_mv 10.2147/OTT.S169094
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6039075</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A583694825</galeid><sourcerecordid>A583694825</sourcerecordid><originalsourceid>FETCH-LOGICAL-c507t-3a303685b4e8ccb62d5c4e1ee2d2f7cf67f54c313e05c22feaf035a3a6f7c5023</originalsourceid><addsrcrecordid>eNptkt-LEzEQxxdRvLvqk-8SEORAtmaT3ez2HoTj8Bcc3IP1OaTZSTdnmtQkW-lf4r_r1NazFclDkpnPfCczmaJ4UdEpq-r27d18Pv1SiRmd1Y-K86pqu1LMOH18dD4rLlK6p1SIjtVPizNOacW56M6Ln_MBiHbWW60cGROY0XlIiQRDvMpjROs36xxEosE5onS2G5u3xHqyVtmCz4n8sHkgaUxr0Bl6EiLprVr6kPCyjiFllTGJ8hriFVGehEWCuMHo4FFeI5HKhLH7e8pjv31WPDHKJXh-2CfF1w_v5zefytu7j59vrm9L3dA2l1xxinU0ixo6rReC9Y2uoQJgPTOtNqI1Ta15xYE2mjEDylDeKK4EehvK-KR4t9ddj4sV9BrrwZLlOtqVilsZlJWnHm8HuQwbKSif0bZBgcuDQAzfR0hZrmzatUp5CGOSjLZVI-oW3zApXv2D3ocxYslIsZrhc2rO_lJL5UBabwLm1TtRed10XMzqju3STv9D4ephZXXwYCzaTwJeHwUMoFweUnDjrunpFHyzB3__SwTz0IyKyt3ASRw4eRg4pF8e9--B_TNh_Bcbz9NY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2242502432</pqid></control><display><type>article</type><title>The clinical usefulness of natural killer cell activity in patients with suspected or diagnosed prostate cancer: an observational cross-sectional study</title><source>PubMed (Medline)</source><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Taylor &amp; Francis Open Access</source><creator>Song, Wan ; Yu, Ji Woong ; Jeong, Byong Chang ; Seo, Seong Il ; Jeon, Seong Soo ; Lee, Hyun Moo ; Choi, Han Yong ; Kang, Eun-Suk ; Jeon, Hwang Gyun</creator><creatorcontrib>Song, Wan ; Yu, Ji Woong ; Jeong, Byong Chang ; Seo, Seong Il ; Jeon, Seong Soo ; Lee, Hyun Moo ; Choi, Han Yong ; Kang, Eun-Suk ; Jeon, Hwang Gyun</creatorcontrib><description>To investigate the clinical usefulness of natural killer cell activity (NKA) for detection of prostate cancer (PCa) and prediction of Gleason grade. We prospectively enrolled 221 patients who underwent transrectal ultrasound-guided prostate biopsy for suspected PCa due to elevated prostate-specific antigen (PSA) &gt;2.5 ng/mL or abnormal findings on digital rectal examination (n=146), or who were diagnosed with PCa (n=75) between 2016 and 2017. The NKA was compared according to PCa and Gleason grade. Correlation analysis was used to evaluate associations among NKA, PCa, and Gleason grade, and expressed using distribution dot plots. The absolute risk and relative risk of PCa, and odds ratios at different cut-off values of NKA were calculated. Of the total 221 patients, PCa was identified in 135 (61.9%) patients. When patients were divided according to PCa, there was no significant difference in NKA (1,267.6 vs 1,198.9 pg/mL, =0.491). Furthermore, in 135 patients with PCa, the NKA was not significantly different according to Gleason grade ( =0.893). These results were not changed when confined to the patients with PSA between 2.5 and 10.0 ng/mL ( =0.654 and =0.672, respectively). In addition, there was no significant difference in the risk of PCa at different cut-off values of NKA. These results indicate that NKA does not appear to be very useful for detection of PCa and prediction of Gleason grade. Further large multi-institutional studies are required to verify the role of NKA in PCa detection and Gleason grade prediction.</description><identifier>ISSN: 1178-6930</identifier><identifier>EISSN: 1178-6930</identifier><identifier>DOI: 10.2147/OTT.S169094</identifier><identifier>PMID: 30013368</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Age ; Androgens ; Antigens ; Cancer diagnosis ; Cancer research ; Care and treatment ; Comparative analysis ; Cross-sectional studies ; Cytotoxicity ; Data collection ; Enzalutamide ; Gene expression ; Health aspects ; Immune system ; Immunology ; Immunotherapy ; Killer cells ; Medicine ; Original Research ; Prostate biopsy ; Prostate cancer ; Rectal examination ; Urology</subject><ispartof>OncoTargets and therapy, 2018-01, Vol.11, p.3883-3889</ispartof><rights>COPYRIGHT 2018 Dove Medical Press Limited</rights><rights>2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2018 Song et al. This work is published and licensed by Dove Medical Press Limited 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c507t-3a303685b4e8ccb62d5c4e1ee2d2f7cf67f54c313e05c22feaf035a3a6f7c5023</citedby><orcidid>0000-0001-6386-6520</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2242502432/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2242502432?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30013368$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Song, Wan</creatorcontrib><creatorcontrib>Yu, Ji Woong</creatorcontrib><creatorcontrib>Jeong, Byong Chang</creatorcontrib><creatorcontrib>Seo, Seong Il</creatorcontrib><creatorcontrib>Jeon, Seong Soo</creatorcontrib><creatorcontrib>Lee, Hyun Moo</creatorcontrib><creatorcontrib>Choi, Han Yong</creatorcontrib><creatorcontrib>Kang, Eun-Suk</creatorcontrib><creatorcontrib>Jeon, Hwang Gyun</creatorcontrib><title>The clinical usefulness of natural killer cell activity in patients with suspected or diagnosed prostate cancer: an observational cross-sectional study</title><title>OncoTargets and therapy</title><addtitle>Onco Targets Ther</addtitle><description>To investigate the clinical usefulness of natural killer cell activity (NKA) for detection of prostate cancer (PCa) and prediction of Gleason grade. We prospectively enrolled 221 patients who underwent transrectal ultrasound-guided prostate biopsy for suspected PCa due to elevated prostate-specific antigen (PSA) &gt;2.5 ng/mL or abnormal findings on digital rectal examination (n=146), or who were diagnosed with PCa (n=75) between 2016 and 2017. The NKA was compared according to PCa and Gleason grade. Correlation analysis was used to evaluate associations among NKA, PCa, and Gleason grade, and expressed using distribution dot plots. The absolute risk and relative risk of PCa, and odds ratios at different cut-off values of NKA were calculated. Of the total 221 patients, PCa was identified in 135 (61.9%) patients. When patients were divided according to PCa, there was no significant difference in NKA (1,267.6 vs 1,198.9 pg/mL, =0.491). Furthermore, in 135 patients with PCa, the NKA was not significantly different according to Gleason grade ( =0.893). These results were not changed when confined to the patients with PSA between 2.5 and 10.0 ng/mL ( =0.654 and =0.672, respectively). In addition, there was no significant difference in the risk of PCa at different cut-off values of NKA. These results indicate that NKA does not appear to be very useful for detection of PCa and prediction of Gleason grade. Further large multi-institutional studies are required to verify the role of NKA in PCa detection and Gleason grade prediction.</description><subject>Age</subject><subject>Androgens</subject><subject>Antigens</subject><subject>Cancer diagnosis</subject><subject>Cancer research</subject><subject>Care and treatment</subject><subject>Comparative analysis</subject><subject>Cross-sectional studies</subject><subject>Cytotoxicity</subject><subject>Data collection</subject><subject>Enzalutamide</subject><subject>Gene expression</subject><subject>Health aspects</subject><subject>Immune system</subject><subject>Immunology</subject><subject>Immunotherapy</subject><subject>Killer cells</subject><subject>Medicine</subject><subject>Original Research</subject><subject>Prostate biopsy</subject><subject>Prostate cancer</subject><subject>Rectal examination</subject><subject>Urology</subject><issn>1178-6930</issn><issn>1178-6930</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptkt-LEzEQxxdRvLvqk-8SEORAtmaT3ez2HoTj8Bcc3IP1OaTZSTdnmtQkW-lf4r_r1NazFclDkpnPfCczmaJ4UdEpq-r27d18Pv1SiRmd1Y-K86pqu1LMOH18dD4rLlK6p1SIjtVPizNOacW56M6Ln_MBiHbWW60cGROY0XlIiQRDvMpjROs36xxEosE5onS2G5u3xHqyVtmCz4n8sHkgaUxr0Bl6EiLprVr6kPCyjiFllTGJ8hriFVGehEWCuMHo4FFeI5HKhLH7e8pjv31WPDHKJXh-2CfF1w_v5zefytu7j59vrm9L3dA2l1xxinU0ixo6rReC9Y2uoQJgPTOtNqI1Ta15xYE2mjEDylDeKK4EehvK-KR4t9ddj4sV9BrrwZLlOtqVilsZlJWnHm8HuQwbKSif0bZBgcuDQAzfR0hZrmzatUp5CGOSjLZVI-oW3zApXv2D3ocxYslIsZrhc2rO_lJL5UBabwLm1TtRed10XMzqju3STv9D4ephZXXwYCzaTwJeHwUMoFweUnDjrunpFHyzB3__SwTz0IyKyt3ASRw4eRg4pF8e9--B_TNh_Bcbz9NY</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Song, Wan</creator><creator>Yu, Ji Woong</creator><creator>Jeong, Byong Chang</creator><creator>Seo, Seong Il</creator><creator>Jeon, Seong Soo</creator><creator>Lee, Hyun Moo</creator><creator>Choi, Han Yong</creator><creator>Kang, Eun-Suk</creator><creator>Jeon, Hwang Gyun</creator><general>Dove Medical Press Limited</general><general>Taylor &amp; Francis Ltd</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6386-6520</orcidid></search><sort><creationdate>20180101</creationdate><title>The clinical usefulness of natural killer cell activity in patients with suspected or diagnosed prostate cancer: an observational cross-sectional study</title><author>Song, Wan ; Yu, Ji Woong ; Jeong, Byong Chang ; Seo, Seong Il ; Jeon, Seong Soo ; Lee, Hyun Moo ; Choi, Han Yong ; Kang, Eun-Suk ; Jeon, Hwang Gyun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c507t-3a303685b4e8ccb62d5c4e1ee2d2f7cf67f54c313e05c22feaf035a3a6f7c5023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Age</topic><topic>Androgens</topic><topic>Antigens</topic><topic>Cancer diagnosis</topic><topic>Cancer research</topic><topic>Care and treatment</topic><topic>Comparative analysis</topic><topic>Cross-sectional studies</topic><topic>Cytotoxicity</topic><topic>Data collection</topic><topic>Enzalutamide</topic><topic>Gene expression</topic><topic>Health aspects</topic><topic>Immune system</topic><topic>Immunology</topic><topic>Immunotherapy</topic><topic>Killer cells</topic><topic>Medicine</topic><topic>Original Research</topic><topic>Prostate biopsy</topic><topic>Prostate cancer</topic><topic>Rectal examination</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Song, Wan</creatorcontrib><creatorcontrib>Yu, Ji Woong</creatorcontrib><creatorcontrib>Jeong, Byong Chang</creatorcontrib><creatorcontrib>Seo, Seong Il</creatorcontrib><creatorcontrib>Jeon, Seong Soo</creatorcontrib><creatorcontrib>Lee, Hyun Moo</creatorcontrib><creatorcontrib>Choi, Han Yong</creatorcontrib><creatorcontrib>Kang, Eun-Suk</creatorcontrib><creatorcontrib>Jeon, Hwang Gyun</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>OncoTargets and therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Song, Wan</au><au>Yu, Ji Woong</au><au>Jeong, Byong Chang</au><au>Seo, Seong Il</au><au>Jeon, Seong Soo</au><au>Lee, Hyun Moo</au><au>Choi, Han Yong</au><au>Kang, Eun-Suk</au><au>Jeon, Hwang Gyun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The clinical usefulness of natural killer cell activity in patients with suspected or diagnosed prostate cancer: an observational cross-sectional study</atitle><jtitle>OncoTargets and therapy</jtitle><addtitle>Onco Targets Ther</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>11</volume><spage>3883</spage><epage>3889</epage><pages>3883-3889</pages><issn>1178-6930</issn><eissn>1178-6930</eissn><abstract>To investigate the clinical usefulness of natural killer cell activity (NKA) for detection of prostate cancer (PCa) and prediction of Gleason grade. We prospectively enrolled 221 patients who underwent transrectal ultrasound-guided prostate biopsy for suspected PCa due to elevated prostate-specific antigen (PSA) &gt;2.5 ng/mL or abnormal findings on digital rectal examination (n=146), or who were diagnosed with PCa (n=75) between 2016 and 2017. The NKA was compared according to PCa and Gleason grade. Correlation analysis was used to evaluate associations among NKA, PCa, and Gleason grade, and expressed using distribution dot plots. The absolute risk and relative risk of PCa, and odds ratios at different cut-off values of NKA were calculated. Of the total 221 patients, PCa was identified in 135 (61.9%) patients. When patients were divided according to PCa, there was no significant difference in NKA (1,267.6 vs 1,198.9 pg/mL, =0.491). Furthermore, in 135 patients with PCa, the NKA was not significantly different according to Gleason grade ( =0.893). These results were not changed when confined to the patients with PSA between 2.5 and 10.0 ng/mL ( =0.654 and =0.672, respectively). In addition, there was no significant difference in the risk of PCa at different cut-off values of NKA. These results indicate that NKA does not appear to be very useful for detection of PCa and prediction of Gleason grade. Further large multi-institutional studies are required to verify the role of NKA in PCa detection and Gleason grade prediction.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>30013368</pmid><doi>10.2147/OTT.S169094</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-6386-6520</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1178-6930
ispartof OncoTargets and therapy, 2018-01, Vol.11, p.3883-3889
issn 1178-6930
1178-6930
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6039075
source PubMed (Medline); Publicly Available Content Database (Proquest) (PQ_SDU_P3); Taylor & Francis Open Access
subjects Age
Androgens
Antigens
Cancer diagnosis
Cancer research
Care and treatment
Comparative analysis
Cross-sectional studies
Cytotoxicity
Data collection
Enzalutamide
Gene expression
Health aspects
Immune system
Immunology
Immunotherapy
Killer cells
Medicine
Original Research
Prostate biopsy
Prostate cancer
Rectal examination
Urology
title The clinical usefulness of natural killer cell activity in patients with suspected or diagnosed prostate cancer: an observational cross-sectional study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T23%3A59%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20clinical%20usefulness%20of%20natural%20killer%20cell%20activity%20in%20patients%20with%20suspected%20or%20diagnosed%20prostate%20cancer:%20an%20observational%20cross-sectional%20study&rft.jtitle=OncoTargets%20and%20therapy&rft.au=Song,%20Wan&rft.date=2018-01-01&rft.volume=11&rft.spage=3883&rft.epage=3889&rft.pages=3883-3889&rft.issn=1178-6930&rft.eissn=1178-6930&rft_id=info:doi/10.2147/OTT.S169094&rft_dat=%3Cgale_pubme%3EA583694825%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c507t-3a303685b4e8ccb62d5c4e1ee2d2f7cf67f54c313e05c22feaf035a3a6f7c5023%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2242502432&rft_id=info:pmid/30013368&rft_galeid=A583694825&rfr_iscdi=true